Cisatracurium Besylate
Cisatracurium Besylate structure
|
Common Name | Cisatracurium Besylate | ||
|---|---|---|---|---|
| CAS Number | 96946-42-8 | Molecular Weight | 1243.479 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C65H82N2O18S2 | Melting Point | 90-93ºC | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS06 |
Signal Word | Danger | |
|
The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
Anesthesiology 82 , 1139-1145, (1995) Atracurium is a mixture of ten stereoisomers. 51W89, one of these isomers, is a potent nondepolarizing intermediate-duration neuromuscular blocking agent. Preclinical studies have shown 51W89 to be significantly more potent than atracurium but with a similar ... |
|
|
The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
Anesthesiology 82 , 1131-1138, (1995) Atracurium consists of a mixture of ten stereoisomers. One of these isomers, 51W89, is a potent intermediate-acting nondepolarizing neuromuscular blocking agent. Its ED95 is 0.05 mg.kg-1 in patients receiving nitrous oxide/opioid anesthesia. In preclinical tr... |
|
|
Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat.
Anesthesiology 122(2) , 363-73, (2015) Rodent mesenchymal stem/stromal cells (MSCs) enhance repair after ventilator-induced lung injury (VILI). We wished to determine the therapeutic potential of human MSCs (hMSCs) in repairing the rodent lung.In series 1, anesthetized rats underwent VILI (series ... |